Authors:
de Vriendt, CA
van Sassenbroeck, DK
Rosseel, MT
van de Velde, EJ
Verstraete, AG
Vander Heyden, Y
Belpaire, FM
Citation: Ca. De Vriendt et al., Development and validation of a high-performance liquid chromatographic method for the determination of gamma-hydroxybutyric acid in rat plasma, J CHROMAT B, 752(1), 2001, pp. 85-90
Citation: A. Hemeryck et al., Metoprolol-paroxetine interaction in human liver microsomes: Stereoselective aspects and prediction of the in vivo interaction, DRUG META D, 29(5), 2001, pp. 656-663
Authors:
De Paepe, P
Van Sassenbroeck, DK
Belpaire, FM
Buylaert, WA
Citation: P. De Paepe et al., Influence of naloxone on the increased sensitivity to propofol during hypovolemia in the rat, CRIT CARE M, 29(5), 2001, pp. 997-999
Authors:
De Letter, EA
De Paepe, P
Clauwaert, KM
Belpaire, FM
Lambert, WE
Van Bocxlaer, JF
Piette, MHA
Citation: Ea. De Letter et al., Is vitreous humour useful for the interpretation of 3,4-methylenedioxymethamphetamine (MDMA) blood levels? Experimental approach with rabbits, INT J LEGAL, 114(1-2), 2000, pp. 29-35
Citation: A. Hemeryck et al., Effect of selective serotonin reuptake inhibitors on the oxidative metabolism of propafenone: In vitro studies using human liver microsomes, J CL PSYCH, 20(4), 2000, pp. 428-434
Authors:
Hemeryck, A
Lefebvre, RA
De Vriendt, C
Belpaire, FM
Citation: A. Hemeryck et al., Paroxetine affects metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers, CLIN PHARM, 67(3), 2000, pp. 283-291
Authors:
De Paepe, P
Belpaire, FM
Rosseel, MT
Van Hoey, G
Boon, PA
Buylaert, WA
Citation: P. De Paepe et al., Influence of hypovolemia on the pharmacokinetics and the electroencephalographic effect of propofol in the rat, ANESTHESIOL, 93(6), 2000, pp. 1482-1490
Authors:
Pan, LP
Vander Stichele, R
Rosseel, MT
Berlo, JA
De Schepper, N
Belpaire, FM
Citation: Lp. Pan et al., Effects of smoking, CYP2D6 genotype, and concomitant drug intake on the steady state plasma concentrations of haloperidol and reduced haloperidol in schizophrenic inpatients, THER DRUG M, 21(5), 1999, pp. 489-497
Citation: L. Pan et Fm. Belpaire, In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol, EUR J CL PH, 55(8), 1999, pp. 599-604
Citation: A. Hemeryck et al., Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes, EUR J CL PH, 54(12), 1999, pp. 947-951
Authors:
De Paepe, P
Belpaire, FM
Van Hoey, G
Boon, PA
Buylaert, WA
Citation: P. De Paepe et al., Influence of hypovolemia on the pharmacokinetics and the electroencephalographic effect of etomidate in the rat, J PHARM EXP, 290(3), 1999, pp. 1048-1053